Specialty Pharmacy

Researchers weigh risk and reward in starting early antiretroviral therapy in patients with HIV.

Liver conserving treatments are sorely needed.

Patients with chronic conditions like HIV and hepatitis C could no longer be denied coverage due to pre-existing conditions under the ACA.

Prolonged steroid treatment may put inflammatory bowel disease patients at greater risk for steroid-associated adverse events.

Test diagnoses RA with better accuracy by detecting synthetic citrullinated peptides.

LQG participants show improvements in lung function, overall health, mental health, and quality of life.

Diabetes has a tremendous global impact, but developing nations often struggle to help patients deal with their disease.

Trial data shows positive results across a range of difficult-to-treat patients with MM.

Amy Grogg, PharmD, senior vice president of Strategy and Commercialization at AmerisourceBergen Specialty Group, discusses developing trends in specialty drug cost management.

Research may lead to gel that prevents transmission of HIV, hepatitis C and the Ebola virus.

HIMSS is working to determine the readiness of providers to participate in the types of value-based payment models that CMS is moving toward.

Researchers examine impact of probiotics on inflammatory bowel disease.

XSTAT 30 is typically used to control life-threatening bleeding in military settings.

A pharmacy must pay $60,000 in a settlement resolving allegations that it violated the Controlled Substances Act and the Combat Methamphetamine Epidemic Act of 2005.

An HCV vaccine, while elusive, offers the best hope to eradicate the virus.

Top news of the week in cancer drug development.

Eating before bed can have a significant impact on the development of nonalcoholic fatty liver disease.

Researchers consider the ramifications of using organs from infected patients to save lives.

Liver damage caused by hepatitis C may eventually be overcome through stem cell therapy.

Researchers target effect of various medical conditions on platelet function.

New treatment option for patients who no longer respond to Xalkori.

Enhanced screening and treatment in high-risk populations could eliminate virus.

Top stories of the week on Specialty Pharmacy Times.

Researchers target how cancer cells avoid treatment.

Clean needle programs have reduced HIV incidence among injection drug abusers by 80% from 1990 to 2006.

Shopping around carefully for plans will be important for Medicare Part D enrollees.

Through a voluntary field safety notification, Insulet Corporation is notifying consumers and health care professionals about a slight increase in reports in which the OmniPod's needle mechanism to deliver insulin fails to deploy or is delayed.

Asthma may increase the likelihood of chronic migraines in patients with episodic migraines.

CMS report shows spending rates are lower compared with the years prior to health care reform.

Treatment shows clinically meaningful reduction in the number of cancer cells in patients with relapsed or refractory chronic lymphocytic leukemia.